申请人:Finetech Laboratories Ltd.
公开号:US06492522B1
公开(公告)日:2002-12-10
The present invention relates to a new process for the preparation of acetylcholinesterase inhibitors of formula (I) or a salt thereof, wherein: R1 is N-acyl-4-piperidyl; N-alkoxycarbonyl-4-piperidyl; N-alkyl-4-piperidyl; N-benzyl-4-piperidyl; N-(&ohgr;-aralkyl)-4-piperidyl; 4-pyridyl; R4, R5, R6, and R7 are identical or different and each represents hydrogen, straight-chain or branched alkyl, aryl, hydroxy, alkoxy, aryloxy, benzyloxy, acyloxy, alkylthio, arylthio, benzylthio, acylamino, phthalimido or halogen; n is 1, 2 or 3; m is 1, 2, 3, 4, or 5. This process comprises cyclisation of a compound of formula (II) or salts thereof, wherein R1, R4, R5, R6 and R7, m and n are as defined above; R2 is selected from a derivatised or non-derivatised carboxyl, cyano, N-substituted aminocarbonyl groups or hydrogen; R3 is selected from a derivatised or non-derivatised carboxyl, cyano or N-substituted aminocarbonyl groups, optionally in the presence of acids and/or solvents. One of the most potent acetylcholinesterase inhibitors of the class of compounds prepared according to the present invention is donepezil.
本发明涉及一种制备式(I)或其盐的乙酰胆碱酯酶抑制剂的新工艺,其中:R1为N-酰基-4-哌啶基;N-烷氧羰基-4-哌啶基;N-烷基-4-哌啶基;N-苄基-4-哌啶基;N-(&ohgr;-芳基烷基)-4-哌啶基;4-吡啶基;R4、R5、R6和R7相同或不同,每个代表氢、直链或支链烷基、芳基、羟基、烷氧基、芳氧基、苄氧基、酰氧基、烷硫基、芳硫基、苄硫基、酰基氨基、邻苯二甲酰亚氨基或卤素;n为1、2或3;m为1、2、3、4或5。该工艺包括将式(II)化合物或其盐环化,其中R1、R4、R5、R6和R7、m和n如上定义;R2选择自衍生或非衍生羧基、氰基、N-取代氨基羰基基团或氢;R3选择自衍生或非衍生羧基、氰基或N-取代氨基羰基基团,可选地在酸和/或溶剂的存在下。根据本发明制备的化合物类中最有效的乙酰胆碱酯酶抑制剂之一是多奈哌齐。